In the BioHarmony Drug Report Database

"Preview" Icon

Raltegravir

Isentress, Isentress Hd (raltegravir) is a small molecule pharmaceutical. Raltegravir was first approved as Isentress on 2007-10-12. It is used to treat HIV infections in the USA. It has been approved in Europe to treat HIV infections. Isentress’s patents are valid until 2032-03-30 (FDA).

 

Trade Name

 

Isentress
 

Common Name

 

raltegravir
 

ChEMBL ID

 

CHEMBL254316
 

Indication

 

hiv infections
 

Drug Class

 

Antivirals: integrase inhibitors

Image (chem structure or protein)

Raltegravir structure rendering